Joanne Klon
Chief Medical Officer
Replay available
Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Andrew McKibben
SVP of Strategic Finance and Investor Relations
James Condoulas
Analyst, Stifel
Chris Peetz
Chief Executive Officer
Mike Olds
Analyst, Morgan Stanley
Eric Bierkolt
Chief Financial Officer
Charles Wallace
Analyst, HC Wainwright
Manny Faruja
Analyst, LeadRank Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.059 Good afternoon, and welcome to Merham Pharmaceuticals' fourth quarter and full year 2025 00:00:06.059 -- 00:00:10.806 conference call. My name is Elliot, and I'll be your operator today. 00:00:10.806 -- 00:00:14.270 All lines are currently in listen only mode, and there will be an opportunity for Q&A 00:00:14.270 -- 00:00:16.994 after management's prepared remarks. 00:00:16.994 -- 00:00:21.801 I'd now like to hand the conference over to Andrew McKibben, SVP of Strategic Finance 00:00:21.801 -- 00:00:25.944 and Investor Relations. Please go ahead. 00:00:26.587 -- 00:00:28.972 Thank you, Elliot, and good afternoon, everyone. 00:00:28.972 -- 00:00:33.476 I'd like to welcome you to Merim Pharmaceuticals' fourth quarter and full year 2025 conference 00:00:33.476 -- 00:00:38.361 call. I'm joined today by our Chief Executive Officer, Chris Peetz, our Chief Medical 00:00:38.361 -- 00:00:42.265 Officer, Joanne Klon, and Eric Bierkolt, our Chief Financial Officer. 00:00:42.265 -- 00:00:46.629 Peter Radovich, our President and Chief Operating Officer, is unable to join us today 00:00:46.629 -- 00:00:49.992 as he's attending an international commercial event. 00:00:49.992 -- 00:00:53.536 Earlier this afternoon, Merim issued a press release reporting our fourth quarter and 00:00:53.536 -- 00:00:58.550 full year 2025 financial results. Copies of the press release and our SEC filings 00:00:58.550 -- 00:01:01.595 are available in the Investors section of our website. 00:01:01.595 -- 00:01:05.100 Before we start, I'd like to remind you that during the course of this conference call, 00:01:05.100 -- 00:01:09.947 we will be making certain forward-looking statements based on management's current expectations, 00:01:09.947 -- 00:01:13.612 including sta...